The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCAR-T 2019 | CLL and CAR-T
Saar Gill, MD, PhD, University of Pennsylvania, Philadelphia, PA, is joined by Jordan Gauthier, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, and Tanya Siddiqi, MD, City of Hope, Duarte, CA, in a discussion on CAR T-cell therapy in chronic lymphocytic leukemia (CLL), in the era of venetoclax, ibrutinib, rituximab, and novel combinations. This discussion took place at the 1st International Workshop on CAR-T, held in Miami, FL. In this introductory discussion T-cell biology and leveling the field in CAR-T are spoken about in depth.
